Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
Mayo Clinic
Mayo Clinic
OHSU Knight Cancer Institute
National Institutes of Health Clinical Center (CC)
University of Washington
Fred Hutchinson Cancer Center